For years, she wanted a child. After a decade of waiting, hope and uncertainty, pregnancy finally arrived carrying both joy and fear in equal measure. What followed, however, was not the soft, instinctive transition into motherhood that culture often promises, but a physically traumatic birth, emotional numbness and a long struggle to recognise herself in her new life.

During pregnancy, she found herself largely alone. Her husband, though supportive and loving, was frequently absent, consumed by the demands of a startup consultancy he had recently founded with two academic partners.

Medical appointments, including an amniocentesis prompted by concerns over possible chromosomal abnormalities, were often faced without him because he was abroad for work.

She attended prenatal classes, but support systems felt limited. Only one person in her close circle had children, and her relationship with her own mother, who lived in Italy, was strained. The isolation deepened her anxiety, particularly because childbirth itself frightened her.

When she raised those fears with her general practitioner, she recalls receiving a familiar reassurance that did little to ease them.“Don’t worry, birth isn’t an illness,” her male GP told her. “It’s all perfectly natural.”She felt the dismissal ignored her lived reality. She was asthmatic and suffering from undiagnosed endometriosis that caused severe pain every few weeks.

Pregnancy did not feel simple or natural. It felt uncertain and medically significant.Still, she felt deeply connected to the child growing inside her. She recognised her daughter through movement alone—the shape of limbs pressing against skin, strong kicks in response to passing sirens, a physical presence both strange and intimate.

She imagined a temperament already forming: long legs like her father, a temper like her own.She expected love to be immediate. After waiting so long, how could it not be?Her due date passed. Then another week.

Then another. At more than 44 weeks pregnant, she says she had to insist repeatedly before her GP agreed to induction. Only when hospital monitoring showed signs of fetal distress did medical staff finally intervene and break her waters.

Labour lasted 20 hours.

She describes induced labour not as a gradual progression but as a sudden collapse into nausea, pain and exhaustion. Hours passed with no progress. She was unable to receive an epidural at first because she was not dilating. The pain became all-consuming.

At one point, fearing the worst, she asked her husband to make a promise: if doctors had to choose between saving her life and their child’s, he should choose the baby.“I am not going to lose either of you,” he replied.

She remembers University College Hospital at the time as a place that inspired little confidence—a crumbling Victorian building with filthy bathrooms, blood on the floors and junior doctors exhausted by punishing shifts. Around her, the maternity ward echoed with the sounds of women in labour: groans, cries, gasps and fear.Eventually she received an epidural, but the baby remained stuck.

Just before midnight, an emergency forceps delivery and episiotomy were performed. Her husband later told her there were 13 people in the room.Then their daughter arrived.She weighed just under 4.5 kilograms—almost 10 pounds.

The mother had lost so much blood that the experience felt, in her words, like surviving a car crash. Her husband, standing in blood-soaked jeans, was overwhelmed with joy.“Isn’t she wonderful?” he said.She felt nothing.

She describes the absence of emotion not as rejection, but as total numbness, as though the epidural that had numbed her body had also severed access to feeling. She spent the night awake in the recovery ward waiting for the expected rush of maternal love that never came, listening to other women crying as anaesthesia wore off.

Instead, she felt transported back to boarding school dormitories, where she had learned early to suppress everything except anger.“Rage has served me quite often as a stimulant against exhaustion,” she writes. “Every woman who goes through childbirth has, I believe, been through the equivalent of war.

”She compares childbirth to trauma rather than celebration, arguing that many women leave the experience carrying symptoms closer to post-traumatic stress than to joy.

She believes poor maternity care intensified that reality.Her experience took place during years of severe strain on Britain’s National Health Service, when long-term underfunding and overstretched staff affected standards of care.

But she also sees a broader cultural issue: motherhood itself, she argues, is often insufficiently respected.At the time, general practice and obstetrics were still dominated by men.

She does not argue that male doctors cannot provide excellent care, but believes many failed to understand how dangerous childbirth could still be, or how often women’s pain was normalised rather than addressed.She was discharged the next day after a blood transfusion and severe physical trauma. She could barely walk.

Her husband worried about her physical recovery, but neither of them recognised the mental damage taking shape beneath it.When the baby began crying—night after night, almost without pause motherhood became a contest between exhaustion and fury.

“Once our baby began to cry relentlessly every night, all night, it felt like a battle between my rage and hers,” she recalls.Then one day, something changed.Her daughter, whose eyes had until then seemed distant and unfocused, suddenly looked directly at her. Then came a smile—clear, unmistakable and full.It was not simply recognition. It felt like acceptance.

“She seemed not only to recognise me, but to greet me with unconditional love and delight,” she writes.She understood intellectually that infant smiles are biological survival mechanisms, but the emotional impact was overwhelming.

The joy felt so sharp it was almost painful.“Oh!” she remembers saying. “It’s you. It’s you.”That first smile altered everything.The sleepless nights did not disappear. The crying continued. But something fundamental shifted in her understanding of motherhood, of love and even of her own mother.

Her relationship with her mother, long marked by pain and distance, softened. She began to understand her mother’s own unresolved grief and emotional absences not simply as cruelty, but as the result of childhood bereavement and wounds never healed.Motherhood brought not only responsibility, but perspective.

As a writer, she found that literature had offered little preparation for the reality of childbirth. Victorian novels she loved moved quickly past pregnancy and motherhood, treating them as narrative transitions rather than lived experiences.

Even contemporary women writers often avoided describing the devastation of birth itself.When she included the physical brutality of childbirth in her 1996 novel A Vicious Circle, critics attacked what one reviewer called “revolting details.”

Yet she says she had still softened the truth, giving her fictional heroine an instant maternal bond she herself had not felt.Years later, much changed. Hospitals improved. Her GP practice became staffed by younger, mostly women doctors. She had a second child, a son, whose birth was entirely different and with whom she bonded immediately.

Her daughter, Leon, grew into a novelist herself—healthy, loving and brilliant.Looking back, she says motherhood brought both unimaginable suffering and extraordinary love.

Public conversation often reduces it to either sentimental joy or unbearable hardship. The truth, she argues, is both.And if the early days felt like darkness, what remained was not the trauma alone, but the light that followed.

India’s largest drugmaker by market value said it would pay $14 per share for Organon, representing a premium of more than 24% to Organon’s April 24 closing price, as it accelerates its strategy to deepen exposure to higher-margin specialty therapies including dermatology, oncology and obesity treatments.

The acquisition also strengthens Sun Pharma’s presence in women’s health and gives it entry into biosimilars, while broadening its reach into markets such as China, Brazil and other emerging economies where its footprint has been comparatively limited.

Sun Pharma shares closed 7% higher on Monday, adding 271.36 billion rupees ($2.88 billion) in market value, after rising as much as 9% earlier in the session. Organon shares rose 16% in premarket U.S. trading to $14.06.The deal includes Organon’s net debt of about $8.6 billion as of Dec. 31, 2025.

Sun said it would finance the transaction through a combination of existing cash reserves and committed bank financing.As of the same date, Sun Pharma’s debt stood at roughly $198.4 million, while annual profit was about $1.16 billion, giving it relatively strong balance sheet flexibility compared with the scale of the acquisition.

Analysts said the transaction would materially increase Sun’s earnings capacity and strengthen its long-term strategic positioning.Nuvama Institutional Equities analyst Shrikant Akolkar said the acquisition would effectively double Sun’s revenue and EBITDA by adding approximately $6.2 billion in sales with EBITDA margins of around 30%.

He said the transaction could be 30% to 40% earnings-per-share accretive by fiscal year 2028.“Funding is coming from a strong balance sheet, and debt concerns should ease by the third year,” Akolkar said, adding that the deal positions Sun to become a more dominant global pharmaceutical player by the end of the decade.

Organon’s portfolio includes more than 70 women’s health and general medicine products sold across around 140 countries, offering Sun a steady cash-generating business alongside its specialty drug pipeline.

The acquisition comes as Indian drugmakers with significant U.S. exposure face pressure from shifting U.S. tariff policies and pricing challenges in the generics market, prompting companies to seek stronger margins through branded specialty medicines and broader geographic diversification.

While analysts view the deal as strongly positive for earnings, some noted it may not dramatically alter Sun’s competitive standing in the U.S. market because Organon’s American business remains relatively modest.

Still, the transaction represents a major strategic step for Sun Pharma as it seeks to reduce dependence on traditional generic drug sales and strengthen its position as a global branded and specialty pharmaceuticals player.

The initiative—part of a five-year, state-wide campaign—seeks to reach 25,500 young women across 11 universities in Uttarakhand with lifesaving education on early detection and risk reduction. The programme at Doon University will bring together medical experts, public health advocates, and students in an interactive, data-driven effort to change the trajectory of breast cancer outcomes in India.

Breast cancer remains one of the most prevalent cancers worldwide. In India, one in 28 women will develop the disease in their lifetime—rising to one in 22 in urban areas—and younger women are increasingly at risk.

Globally, experts warn that cultural myths, delayed detection, and inadequate screening continue to drive mortality rates.

The Doon University campaign seeks to close these gaps by challenging the misconception that breast cancer is solely an “older woman’s disease,” promoting self-examination and timely medical consultation, and equipping students with multilingual resources to extend awareness within their communities.

Event Highlights – 13 August 2025

The event on 13 August 2025 will open at 10:00 am with an address by the Vice Chancellor of Doon University, followed by an expert-led interactive session with Col. Mayank Chaubey and a team of doctors from 10:30 am to 12:30 pm.

The programme will also see the launch of the Doon University Youth Council for Breast Health, the distribution of self-examination guides in multiple languages, and a live question-and-answer session with healthcare professionals.

Concluding the morning, Dr. Rajesh Bhatt will present a psychological perspective on well-being from 12:30 pm to 1:30 pm.

This initiative builds on the momentum of the campaign’s first event, held on 18 July 2025 at Military Hospital Dehradun, where young women from the cantonment turned out in large numbers, surpassing expectations and engaging in lively, insightful discussions.

A Model for International Outreach

The BCYW Foundation’s Uttarakhand model is drawing attention from health advocacy groups worldwide as a promising and replicable blueprint for community-led, youth-focused cancer prevention. Its approach—embedding health literacy into academic environments—ensures that awareness begins early, within trusted spaces of learning. By combining medical expertise with student-driven outreach, the initiative not only addresses immediate knowledge gaps but also fosters a generation of informed health advocates.

This strategy aligns closely with the World Health Organization’s (WHO) global objectives for early detection, lifestyle-based prevention, and equitable access to information. International observers view it as a case study in how local initiatives, when well-structured, can resonate beyond national borders.

At a time when global cancer rates are climbing and younger demographics are increasingly affected, the upcoming Doon University event highlights the urgency of merging public health diplomacy with grassroots engagement. It transforms university campuses into hubs of wellness activism—places where education, prevention, and empowerment intersect to create lasting change, both locally and globally.